Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2025-02-21

FDA Approved: BOSENTAN — Supplemental Application (Sun Pharmaceutical Industries, Inc.)

View source ↗

Summary

FDA approved a supplemental application for Bosentan from Sun Pharmaceutical, approving a generic version of bosentan for treating pulmonary arterial hypertensi…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Bosentan (Bosentan)

Snippet

SUPPL AP for BOSENTAN (BOSENTAN)